Follow-up studies in other tumor models of, e.g., skin, breast, and lung cancer with PDGFR-negative malignant cells also demonstrated pro-tumoral effects mediated by different PDGF ligands that were associated with increased fibroblast recruitment [59–63]. The gene discussed is PDGFRB; the disease is neoplasm.